1 Cantharidin, an inhibitor of protein phosphatase types 1 (PP1) and 2A (PP2A), increased basal tone of bovine isolated coronary artery rings (CARs) with and without endothelium in a time-and concentration-dependent manner with pEC 50 values of about 5.1 and 5.2, respectively, for both preparations. 2 b-Adrenoceptor stimulation with isoprenaline (Iso; 0.03 ± 100 mM) or inhibition of phosphodiesterase activity by 3-isobutyl-1-methylxanthine (IBMX; 10 ± 1000 mM), respectively, relaxed CARs precontracted with KCl (75 mM). CARs with and without endothelium showed no dierence in the relaxing response to Iso and IBMX, respectively. 3 Cantharidin (3 mM) attenuated vasorelaxation induced by Iso (0.03 ± 100 mM) in CARs with and without endothelium in a time-dependent manner, whereas vasorelaxation induced by IBMX (10 ± 1000 mM) was not attenuated by 3 mM cantharidin. 4 Cantharidin (3 mM) did not aect cyclic AMP content in bovine cultured vascular cells, i.e. coronary artery smooth muscle cells (BCs), aortic endothelial cells (BAECs) and aortic smooth muscle cells (BASMCs), either under basal conditions, after b-adrenoceptor stimulation (Iso) or inhibition of phosphodiesterase activity (IBMX), respectively. 5 Cantharidin inhibited protein phosphatase activity in homogenates from bovine coronary artery rings with a pIC 50 of about 6.0. In homogenates of bovine cultured vascular cells pIC 50 values of cantharidin amounted to about 6.5 for BCs, 6.7 for BAECs and 6.7 for BASMCs, respectively. 6 It was concluded that cantharidin dierently aects vasorelaxation due to stimulation of badrenoceptors (Iso) or inhibition of phosphodiesterase activity (IBMX), respectively. The attenuation of b-adrenoceptor-mediated vasorelaxation by phosphatase inhibition is not due to diminished adenosine 3' : 5'-cyclic monophosphate (cyclic AMP) generation but could be evidence for dierent subcellular compartments of cyclic AMP.
Introduction
Reversible protein phosphorylation is involved in the regulation of a wide variety of cellular processes re¯ecting the balance between protein kinase and protein phosphatase activities. In the mammalian heart, at least four types of serine/ threonine protein phosphatases have been identi®ed: protein phosphatases type 1, 2A, 2B and 2C (for reviews see Shenolikar & Nairn, 1991, and Hunter, 1995) . The study of phosphatases has been facilitated by the availability of cell membrane permeable protein phosphatase inhibitors like, for example, okadaic acid, calyculin A or cantharidin. Okadaic acid, a toxin isolated from black sponges (Halichondria okadai), causes vasoconstriction in dierent experimental systems (Shibata et al., 1982; Ozaki et al., 1987a,b; Gong et al., 1992) . Cantharidin is another natural toxicant produced by as many as 1500 dierent species of blister beetles with the spanish¯y Cantharis vesicatoria probably being the best known source (Honkanen, 1993) . Moreover, cantharidin is a potent vesicant and toxicant in mammals with structural similarity to commercial herbicides like endothall and endothall thioanhydrid. The inhibition of protein phosphatases in vivo may be the cause of sublethal eects and death (Li & Casida, 1992; Polettini et al., 1992) . Recently, it has been demonstrated, that cantharidin increases force of contraction in guinea-pig isolated papillary muscles (Neumann et al., 1995) like okadaic acid (Neumann et al., 1993) and calyculin A (Neumann et al., 1994) . Moreover, cantharidin inhibits type 1 and 2A phosphatase activity of phosphatases puri®ed from guinea-pig ventricles and increases the phosphorylation state of various target proteins, e.g. phospholamban (Neumann et al., 1995) . In contrast to okadaic acid, the eects of cantharidin on contractility, second messenger accumulation and protein phosphatase activity in vasculature have hitherto not been investigated. Thus, the eects of cantharidin on contractility of bovine isolated coronary artery rings and activity of phosphatases from bovine coronary arteries and cultured vascular cells were studied. Based on these data we investigated the interaction between b-adrenoceptor-mediated vasorelaxation and phosphatase inhibition in bovine isolated coronary artery rings (CARs) with and without endothelium.
Methods

Preparation of bovine isolated coronary artery rings (CARs) and experimental protocol
Bovine hearts were obtained from a local slaughterhouse. Immediately after removal from the animals, hearts were placed into Krebs-Henseleit solution (KHS) of the following composition (mM): NaCl 118, NaHCO 3 25, CaCl 2 2.5, KCl 4.7, KH 2 PO 4 1.2, MgSO 4 1.2, glucose 11.1 and ethylenedinitrilotetraacetic acid 0.026. Left coronary arteries (anterior descending branch) were cleaned of connective tissue and cut into rings with an approximate internal diameter of 4 mm (approximately 70 mg wet weight). The endothelium was removed by rubbing the intimal surface with the tip of a forceps. Rings were mounted in organ chambers similar to those used by MuÈ gge & Harrison (1991) and changes in isometric force of contraction were recorded. CARs were allowed to equilibrate in KHS for 60 min under a basal (resting) tension of 20 mN (Obi et al., 1993) which allowed optimal contractions to KCl (75 mM) to be produced. After washout the presence of an undamaged endothelium was checked by relaxation to bradykinin (1 mM) after precontraction with prostaglandine F 2a (PGF 2a , 1 mM). Rings showing less than 50% relaxation to bradykinin were discarded as having partially damaged endothelium. Supposedly endothelium-free rings showing more than 10% relaxing response to bradykinin were excluded from further experiments. CARs were then exposed to cantharidin or dimethylsulphoxide (DMSO, solvent control) for one hour and contracted once again with KCl (75 mM) without correction of NaCl in the KHS. Then isoprenaline (Iso) or 3-isobutyl-1-methyl xanthine (IBMX), respectively, were added and changes in force of contraction were recorded. All experiments were performed in the presence of indomethacin (10 mM) and atropine (10 mM) (Greenberg et al., 1987; Obi et al., 1993; Auch-Schwelk et al., 1993) to prevent generation of vasoactive prostaglandins and to inhibit cholinergic eects, respectively. The vasoconstriction of CARs due to the high potassium was most probably not mediated by the release of noradrenaline from sympathetic nerve terminals, because noradrenaline (1 ± 100 mM) only caused relaxation not contraction in bovine isolated coronary artery rings (data not shown).
Culture of bovine aortic endothelial cells
Bovine aortic endothelial cells (BAECs) were obtained by collagenase digestion as described by Makarski (1981) , by use of Worthington CLS 2 collagenase (0.1%). Thoracic aortae from freshly slaughtered cows were obtained from a local slaughterhouse. Immediately after removal from the animal, aortae were¯ushed with ice-cold sterile phosphate buered saline solution without Ca 2+ -and Mg 2+ salts (PBS; pH 7.45) containing penicillin (100 iu ml 71 ) and streptomycin (100 mg ml 71 ). Aortae were cleaned of fat and connective tissue, longitudinally dissected and ®xed on a polystyrene plate wrapped with aluminium foil. Segments were rinsed with ethanol (70%) to prevent contamination and to eliminate blood cells. Endothelial cells were carefully scraped o with a scalpel, suspended in endothelial cell culture medium (ECM) composed of medium 199 containing foetal calf serum (20%), L-glutamine (100 mg ml 71 ), amphotericin B (4.3 mg ml 71 ), penicillin (100 iu ml 71 ), streptomycin (100 mg ml 71 ) and gentamicin (50 mg ml 71 ) and centrifuged for 10 min (3666g; 48C). The supernatant was discarded and the pellet was treated with 20 ml collagenase (0.1%) for 10 min at 378C. The resulting collagenase/cell suspension was immediately mixed with an equal volume of ECM and centrifuged again at 48C to stop further digestion. Cells were seeded in tissue culture¯asks and grown in a humidi®ed incubator under an atmosphere of 7.5% CO 2 /21% O 2 at 378C. Culture medium was exchanged the next day and subsequently replaced every second day. Cells reached con¯uence within 5 to 7 days forming monolayers with cobblestone appearance. Because direct identi®cation of endothelial cells by light microscopy can be misleading, cells were characterized by staining with an antibody to factor VIII-related antigen (data not shown). Cells were used for the experiments without any passage or after the ®rst passage.
Culture of bovine vascular smooth muscle cells
Smooth muscle cells from bovine aortae and coronary arteries were obtained by using an explant method (Salih et al., 1992; Ebersole et al., 1993) . After removal of the endothelium with a scalpel, pieces of the arterial wall, about 2 ± 4 mm 2 , were transferred into tissue culture¯asks and allowed to dry for 15 ± 30 min at 378C to improve adhesion to the surface. Then smooth muscle culture medium, composed of Dulbecco's Modi®ed Eagle's Medium (DMEM) containing 10% foetal calf serum, L-glutamine (584 mg ml 71 ) and antibiotics as described for endothelial cells, was carefully added. Cell growth could be detected after 7 to 10 days. Cells were subcultured with trypsin (0.05%)/EDTA (0.02%)-solution. For experiments only cells between passages 2 and 6 were used. Identity and purity of cultured cells was con®rmed by light microscopy and immunohistochemistry by use of a monoclonal antibody directed against a-smooth muscle actin. Immunohistochemical ®ndings were con®rmed by Western blotting with the same antibody showing a single band at approximately 40 kDa ) (data not shown).
Determination of cyclic AMP content
Subcon¯uent monolayers of bovine vascular cells were incubated for 60 min in culture medium containing cantharidin or DMSO (solvent control). Cells were harvested, suspended in PBS and transferred into microcentrifuge tubes. Stimulation of vascular cells (30 min, 378C) was performed by using either isoprenaline or 3-isobutyl-1-methylxanthine, both dissolved in ascorbic acid (0.1%), in the presence of cantharidin (3 mM) or DMSO (control cells). Reaction was stopped by addition of 0.1 M HCl and heating at 958C for 10 min. Tubes were cooled on ice for 10 min, centrifuged at 14,000 g for 15 min and aliquots of the supernatants were used for determination of adenosine 3' : 5'-cyclic monophosphate (cyclic AMP) content. The resulting pellets were dissolved in 0.1 N NaOH and protein contents were determined according to Bradford (1976) . Determination of cyclic AMP content was performed as described previously (Neumann et al., 1989) . All data were referred to protein content.
Determination of protein phosphatase activity
Preparation of homogenates Freshly prepared bovine coronary arteries were powdered in liquid nitrogen and homogenized in medium containing ethylenediaminetetraacetic acid 4 mM and b-mercaptoethanol 0.1% three times for 30 s each with a Polytron PT-MR 3000 (Kinematica AG, Littau, Switzerland). Samples were centrifuged for 20 min at 14,0006g (48C). Bovine vascular cells were trypsinized, collected by centrifugation at 3666g for 10 min (48C) and homogenized in buer containing (in mM): Tris-HCl (pH 7.4) 20, ethylene glycol-bis(b-aminoethylether)-N,N,N,N-tetraacetic acid 2, ethylenedinitrilotetraacetic acid 5, benzamidine 1, phenylmethylsulphonyl¯uoride 0.5 (both used as protease inhibitors) and b-mercaptoethanol (0.1%) by pasting the cells through a needle (0.4619 mm). Samples were centrifuged at 12,0006g for 30 min. The supernatants are called homogenate throughout this work.
Protein phosphatase assay Protein phosphatase activity was determined as described previously (Neumann et al., 1993) . In brief, phosphatase activity was measured with [ Experiments on cyclic AMP accumulation and protein phosphatase activity could not be performed in bovine cultured artery endothelial cells because of the low yield of these cells and the large quantities of these cells needed for the experiments.
Chemicals
Collagenase Typ CLS 2 was obtained from Worthington (Freehold, U.S.A.). Medium 199, DMEM, amphotericin B, (PGF 2a ) and all antibodies used for immunohistochemistry were from Sigma (Deisenhofen, Germany), L-glutamine and penicillin/streptomycin solution were purchased from Serva (Heidelberg, Germany) and Gibco (Eggenstein, Germany), respectively. Gentamicin and trypsine/EDTA solution were obtained from Boehringer Mannheim (Mannheim, Germany). Foetal calf serum was from eurobio (Raunheim, Germany) and Boehringer Mannheim (Mannheim, Germany). (+)-Isoprenaline HCl was from Boehringer Ingelheim (Ingelheim, Germany). Tissue culture¯asks from Becton Dickinson (Heidelberg, Germany) and Sarstedt (NuÈ mbrecht, Germany) were used for the experiments without coating. All other chemicals used were of analytical or best commercial grade available. 
Statistics
Results
In¯uence of cantharidin on force of contraction in bovine isolated coronary artery rings (CARs)
Cantharidin (100 mM) increased force of contraction in CARs with and without endothelium in a time-dependent manner. A signi®cant increase in force of contraction compared to basal tension was detected after 30 min of exposure. Maximal eects (322+24 mN for CARs with endothelium and 279+44 mN for CARs without endothelium) were observed after 75 min ( Figure 1a ). Cantharidin at lower concentrations (30 mM and 10 mM) also increased force of contraction in CARs with endothelium, but the maximum eects observed were smaller (200+26 mN and 201+63 mN) and occurred later, namely after 120 and 165 min, respectively. In CARs without endothelium the maximum eects to cantharidin were 170+19 mN for 30 mM and 153+33 mN for 10 mM and were observed after 135 and 180 min, respectively. Cantharidin at concentrations from 0.1 ± 3 mM did not increase force of contraction in CARs with and without endothelium within 180 min (Figure 1b) . Control rings treated with an appropriate amount of solvent (DMSO) showed no signi®cant changes in force of contraction within 180 min compared to basal (resting) tension. Our data demonstrate that cantharidin increased force of contraction in bovine isolated coronary artery rings in a time-and concentration-dependent manner. The vasoconstrictor eects of cantharidin are endothelium-independent with similar pEC 50 values of about 5.1 and 5.2, for both preparations. Therefore, all experiments in isolated rings focussing on possible eects of cantharidin on vasorelaxation were performed with 3 mM cantharidin because this was the highest concentration of cantharidin devoid of vasoconstrictor eects.
Eects of cantharidin on isoprenaline-or 3-isobutyl-1-methylxanthine-induced vasorelaxation in bovine isolated coronary artery rings (CARs)
Bovine coronary artery rings were incubated for one hour with cantharidin (3 mM) or DMSO (solvent control), respectively, and contracted with KCl (75 mM). Cantharidin (3 mM) alone did not aect force of contraction in endothelium intact rings compared to control rings. Isoprenaline (100 mM)-induced vasorelaxation was attenuated by 3 mM cantharidin in a timedependent manner from 45+6 to 98+13% of KCl value after 60 min in CARs with endothelium ( Figure 2b) . and from 40+4 to 82+12% of KCl value after 60 min in CARs without endothelium (Figure 2c ). Cantharidin (3 mM) attenuated isoprenaline (0.03 ± 100 mM)-induced vasorelaxation in CARs with (Figure 3a , 30 min and Figure 3b , 60 min) and without endothelium (data not shown). In contrast, 3 mM cantharidin did not attenuate the 3-isobutyl-1-methylxanthine (10 ± 100 mM)-induced vasorelaxation in CARs with (Figure 4a , IBMX 100 mM) and without endothelium (Figure 4b , IBMX 100 mM).
Because in these experiments the eects of cantharidin (3 mM) were assessed against dierent levels of relaxation, additional experiments were performed in rings where similar levels of relaxation occurred, namely 59+6% of KCl value for isoprenaline (1 mM, Figure 5a ) and 65+5% of KCl value for IBMX (30 mM, Figure 5b ). Also, in these experiments 3 mM cantharidin attenuated vasorelaxation induced by isoprenaline, whereas vasorelaxation induced by IBMX was not attenuated. Furthermore, the relaxing eect of isoprenaline was not attenuated by 1 mM cantharidin (data not shown).
In¯uence of cantharidin (3 mM) on cyclic AMP content in bovine cultured vascular cells after b-adrenoceptor stimulation (Iso) or inhibition of phosphodiesterase activity (IBMX)
The eects of cantharidin on cyclic AMP content were investigated in bovine cultured vascular cells. We chose 3 mM cantharidin for these experiments on distinct but functionally relevant cell types because of reasons of comparability with our physiological data. Cantharidin 3 mM alone did not aect cyclic AMP content in bovine coronary artery smooth muscle cells (BCs, Figures 6a and 7a) , bovine aortic endothelial cells (BAECs, Figures 6b and 7b ) and bovine aortic smooth muscle cells (BASMCs, Figures 6c and 7c) . Moreover, 3 mM cantharidin also failed to aect cyclic AMP content in BCs after badrenoceptor stimulation (Iso) or phosphodiesterase inhibition (IBMX) (Figures 6a and 7a) . Similar results were obtained in aortic endothelial cells (BAECs, Figures 6b and 7b ) and aortic smooth muscle cells (BASMCs, Figures 6c and 7c ).
Protein phosphatase activity in homogenates of bovine coronary arteries and vascular cells
In homogenates of bovine coronary arteries, cantharidin inhibited phosphatase activity with a pIC 50 of about 6.0 ( Figure  8a ). pIC 50 values of cantharidin amounted to 6.5 in homogenates of bovine coronary artery smooth muscle cells ( Figure  8b ), 6.7 in homogenates of bovine aortic endothelial cells (Figure 8c ) and 6.7 in homogenates of bovine aortic smooth muscle cells (Figure 8d ). 
Discussion
Cantharidin, an inhibitor of protein phosphatase types 1 and 2A, increased force of contraction in bovine isolated coronary artery rings with pEC 50 values of 5.1 and 5.2 for CARs with and without endothelium, respectively (Figure 1a and b) . In contrast, okadaic acid caused both vasodilatation and vasoconstriction in dierent experimental systems. Longlasting contraction of human umbilical arteries, rabbit aorta and guinea-pig taenia caecum due to treatment with okadaic acid were observed by Shibata et al. (1982) , whereas okadaic acid also caused endothelium-independent vasodilatation in pig coronary artery and dog basilar artery precontracted with K + (40 mM; Ashizawa et al., 1989) . Moreover, vasodilatation of canine basilar arteries even under resting tension was demonstrated by Kimura et al. (1993) . The latter ®ndings are in contrast to our results in bovine coronary arteries where cantharidin only elicited vasoconstriction under resting conditions. In additional experiments with calyculin A, another protein phosphatase inhibitor, calyculin A (0.3 mM) increased force of contraction in CARs from 24+2 mN to 30+2 mN after 30 min (n=4), whereas 0.1 mM calyculin A failed to aect force of contraction. Experiments with higher concentrations of calyculin A were not performed because of the prohibitive costs of calyculin A needed in these organ bath experiments. Cantharidin and calyculin A are structurally not related but are both known to inhibit protein phosphatase activity. Both compounds led to vasoconstriction of bovine isolated coronary artery rings. These ®ndings strengthen our hypothesis that the vasoconstrictor eects of cantharidin might be due to inhibition of protein phosphatases. Nevertheless, we cannot completely rule out possible membrane or intracellular eects of cantharidin other than phosphatase inhibiton.
Vascular smooth muscle relaxation is mediated at least in part by cyclic AMP-induced activation of cyclic AMP-dependent protein kinase with subsequent phosphorylation of various protein substrates like, for example, myosin light chain kinase and phospholamban, ultimately resulting in the dephosphorylation of myosin light chains and reduction of intracellular Ca 2+ (Lincoln et al., 1990; 1993). Therefore, vascular smooth muscle contraction results at least in part from inhibition of protein phosphatases activity leading to enhanced phosphorylation of e.g. myosin light chains (Ozaki et al., 1987b; Allessi et al., 1992) . To investigate the interaction between protein phosphatase inhibition and vasorelaxation due to elevation of cyclic AMP content via badrenoceptor stimulation, the eects of cantharidin on isoprenaline-induced vasorelaxation were examined in bovine isolated coronary artery rings. Additional experiments were performed with 3-isobutyl-1-methylxanthine, known to elevate cyclic AMP content via the inhibition of activity of phosphodiesterases. Bovine isolated coronary artery rings with or without endothelium, respectively, showed no signi®cant difference in isoprenaline-induced vasorelaxation indicating that the relaxing response due to b-adrenoceptor stimulation is not dependent on intact endothelium. Moreover, treatment of intact isolated rings with the NO-synthase inhibitor N o -nitro-Larginine (100 mM) for 15 min did not alter either basal tone, K + induced contraction or the relaxing eect of isoprenaline (n=4; data not shown). Thus, involvement of the NO pathway in isoprenaline-induced vasorelaxation is very unlikely. These ®ndings are in contrast to those in the rat thoracic aorta (Gray & Marshall, 1992) , where relaxation due to isoprenaline treatment was found to be strictly dependent on intact endothelium. Whereas isoprenaline was able to relax isolated rings at concentrations ranging from 0.03 to 100 mM, vasorelaxation due to nonspeci®c inhibition of phosphodiesterase activity could only be observed at high concentrations of 3-isobutyl-1-methylxanthine (10 ± 1000 mM) in CARs with and without endothelium. Exposure of CARs with and without endothelium to 3 mM cantharidin only resulted in attenuation of vasorelaxation due to b-adrenoceptor stimulation by isoprenaline, whereas vasorelaxation due to inhibition of phosphodiesterase activity by IBMX remained unchanged. Because both compounds exert their biological eects at least in part by elevation of intracellular cyclic AMP levels, one could speculate that the attenuating eects of cantharidin on vasorelaxation after badrenoceptor stimulation could be due to decreased cyclic AMP levels due to antagonism by cantharidin of b-adrenoceptor agonist eects. Therefore, we investigated the in¯uence of cantharidin on cyclic AMP accumulation in bovine cultured vascular cells. No alterations of cyclic AMP content could be observed either under basal conditions, after b-adrenoceptor stimulation with isoprenaline or inhibition of phosphodiesterase activity by IBMX, respectively. Therefore, it seems unlikely that cantharidin attenuates isoprenaline-induced vasorelaxation by antagonizing b-adrenoceptor agonist eects. Moreover, no evidence is available in the published literature. The crucial role of cyclic AMP in mediating vasorelaxation is supported by our ®ndings that the greater maximum relaxation caused by IBMX than by Iso was accompanied by a greater maximum increase of cyclic AMP accumulation in bovine isolated coronary artery smooth muscle cells.
Cantharidin has been demonstrated by others to inhibit protein phosphatase activity with pIC 50 values varying with the type of phosphatase and its substrate more than with the purity (Eldridge & Casida, 1995) . Thus, pIC 50 values were 7.3 for the native dimer form of PP2A from mouse liver cytosol assayed as phosphorylase a phosphatase activity (Li & Casida, 1992) , 7.4 for PP2A and 6.3 for PP1 from rabbit skeletal muscle (Li et al., 1993) and 6.8 for PP2A and 5.8 for PP1 in assays with phosphohistone as substrate (Honkanen, 1993) . Moreover, cantharidin inhibited PP2A-and PP1-activity puri®ed from guinea-pig ventricles with pIC 50 values of 6.9 and 5.6, respectively, and was assumed to be a useful lead compound in the search for new positive inotropic agents (Neumann et al., 1995) . As depicted in Figure 8a ± d, cantharidin inhibited protein phosphatase activity in homogenates of bovine coronary arteries and homogenates of bovine cultured vascular cells with pIC 50 values ranging from 6 to 6.7. The dierence between pIC 50 values for phosphatase activity and the pEC 50 values of cantharidin with respect to vasoconstriction might be due to dierences in permeability between intact multicellular preparations (CARs) and homogenates of CARs and homogenates of bovine cultured vascular cells. Furthermore, the absence of protein kinase activity in the phosphatase assay system may contribute to these dierences.
In summary, we demonstrate for the ®rst time the inhibitory eects of cantharidin on protein phosphatase activity in vascular cells. Treatment of bovine isolated coronary artery rings with cantharidin resulted in a time-and concentration-dependent vasoconstriction which was endothelium-independent. As cantharidin inhibited protein phosphatase activity in homogenates of bovine coronary arteries and vascular cells, it is suggested that vasoconstriction due to cantharidin is at least in part mediated by phosphatase inhibition. Initial experiments indicate that cantharidin increases the phosphorylation state of contractile proteins, e.g. myosin light chains, in smooth muscle cells (unpublished observations). The dierent eects of cantharidin on vasorelaxation due to b-adrenoceptor stimulation or inhibition of phosphodiesterase activity, cannot be explained by alterations of whole cell AMP content but may be due to compartmentation of cyclic AMP in the smooth muscle (Buxton & Brunton, 1983; Lobaugh & Blackshear, 1990) . Because of the prohibitive costs of okadaic acid and calyculin A, cantharidin might be an economical tool to investigate the eects of protein phosphatase inhibition in the vascular system.
